France Pharmaceutical Manufacturing Market Size & Outlook
The pharmaceutical manufacturing market in France is expected to reach a projected revenue of US$ 40,131.2 million by 2030. A compound annual growth rate of 8.6% is expected of France pharmaceutical manufacturing market from 2024 to 2030.
Revenue, 2023 (US$M)
$22,468.5
Forecast, 2030 (US$M)
$40,131.2
CAGR, 2024 - 2030
8.6%
Report Coverage
France
France pharmaceutical manufacturing market, 2018-2030 (US$M)
Related Markets
France pharmaceutical manufacturing market highlights
- The France pharmaceutical manufacturing market generated a revenue of USD 22,468.5 million in 2023 and is expected to reach USD 40,131.2 million by 2030.
- The France market is expected to grow at a CAGR of 8.6% from 2024 to 2030.
- In terms of segment, conventional drugs (small molecules) was the largest revenue generating molecule type in 2023.
- Conventional Drugs (Small Molecules) is the most lucrative molecule type segment registering the fastest growth during the forecast period.
Pharmaceutical manufacturing market data book summary
| Market revenue in 2023 | USD 22,468.5 million |
| Market revenue in 2030 | USD 40,131.2 million |
| Growth rate | 8.6% (CAGR from 2023 to 2030) |
| Largest segment | Conventional drugs (small molecules) |
| Fastest growing segment | Conventional Drugs (Small Molecules) |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Biologics & Biosimilars (Large Molecules), Conventional Drugs (Small Molecules) |
| Key market players worldwide | Roche Holding AG ADR, Novartis AG ADR, GlaxoSmithKline, Pfizer Inc, Merck & Co Inc, AstraZeneca PLC, Johnson & Johnson, Sanofi SA, Eli Lilly and Co, AbbVie Inc, Thermo Fisher Scientific Inc, Wuxi AppTec Co Ltd, Samsung BioLogics, FUJIFILM Holdings Corp, Lonza Group Ltd, Catalent Inc, Jubilant Pharmova |
Other key industry trends
- In terms of revenue, France accounted for 4.5% of the global pharmaceutical manufacturing market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Europe, Germany pharmaceutical manufacturing market is projected to lead the regional market in terms of revenue in 2030.
- UK is the fastest growing regional market in Europe and is projected to reach USD 37,683.2 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Pharmaceutical Manufacturing Market Scope
Pharmaceutical manufacturing market segmentation & scope
Monoclonal Antibodies
Vaccines
Cell & Gene Therapy
Others
Conventional Drugs (Small Molecules)
Pharmaceutical Manufacturing Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
France pharmaceutical manufacturing market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to pharmaceutical manufacturing market will help companies and investors design strategic landscapes.
Conventional drugs (small molecules) was the largest segment with a revenue share of 50.86% in 2023. Horizon Databook has segmented the France pharmaceutical manufacturing market based on biologics & biosimilars (large molecules), conventional drugs (small molecules) covering the revenue growth of each sub-segment from 2018 to 2030.
- France Pharmaceutical Manufacturing Molecule Type Outlook (Revenue, USD Million, 2018-2030)
- Biologics & Biosimilars (Large Molecules)
- Monoclonal Antibodies
- Vaccines
- Cell & Gene Therapy
- Others
- Conventional Drugs (Small Molecules)
- Biologics & Biosimilars (Large Molecules)
- France Pharmaceutical Manufacturing Drug Development Type Outlook (Revenue, USD Million, 2018-2030)
- Outsource
- In-house
- France Pharmaceutical Manufacturing Formulation Outlook (Revenue, USD Million, 2018-2030)
- Tablets
- Capsules
- Injectables
- Sprays
- Suspensions
- Powders
- Other Formulations
- France Pharmaceutical Manufacturing Routes of Administration Outlook (Revenue, USD Million, 2018-2030)
- Oral
- Topical
- Parenterals
- Inhalations
- Other Routes of Administration
- France Pharmaceutical Manufacturing Therapy Area Outlook (Revenue, USD Million, 2018-2030)
- Cardiovascular Diseases
- Pain
- Diabetes
- Cancer
- Respiratory Diseases
- Other Diseases
- France Pharmaceutical Manufacturing Prescription Requirements Outlook (Revenue, USD Million, 2018-2030)
- Prescription Medicines
- Over-the-counter (OTC) Medicines
- France Pharmaceutical Manufacturing Age Type Outlook (Revenue, USD Million, 2018-2030)
- Children & Adolescents
- Adults
- Geriatric
- France Pharmaceutical Manufacturing Sales Channel Outlook (Revenue, USD Million, 2018-2030)
- Retail
- Non-retail
Reasons to subscribe to France pharmaceutical manufacturing market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of France pharmaceutical manufacturing market databook
-
Our clientele includes a mix of pharmaceutical manufacturing market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the France pharmaceutical manufacturing market , including forecasts for subscribers. This country databook contains high-level insights into France pharmaceutical manufacturing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
France pharmaceutical manufacturing market size, by molecule type, 2018-2030 (US$M)
France Pharmaceutical Manufacturing Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
